Promega Corporation

Cell Health Assays

Then it's time to use Promega Apoptosis products!

Then it's time to simplify your apoptosis detection!

Simple, sensitive, optimised detection of apoptosis and the mechanisms of cell death, whatever your sample type or application!

At the forefront of apoptosis detection technology our range of solutions to detect apoptosis meet the needs of most investigators.

From tools for classical techniques like immunochemistry to analyse apoptotic cell populations, Dead End™  Fluorometric or Colorimetric kits to detect nuclear DNA fragmentation by TUNEL staining, antibodies to detect key apoptosis biomarkers and our unique range of simple, rapid and ultra-sensitive Caspase®-Glo assays based on luminogenic caspase substrates to revolutionise caspase assays.

Cell Health Assays Categories

ADME Assays Our wide selection of bioluminescent enzyme substrates for proteases and metabolic enzymes such as CYPs and MAO, among others, provide powerful tools for the ADME-Tox screen.

Apoptosis Assays Get more data in less time when you multiplex cell health biomarkers. Measure one or multiple biomarkers in vitro or in situ to detect early or late events of apoptosis and get a quick status update on targeted cells.

Cell Viability Assays Easily compare the number of live cells/number of dead cells in a single well to get better consistency of data. Normalized data allows data to be easily compared from well-to-well, plate-to-plate and day-to-day.

Cytotoxicity Assays Promega offers multiple readouts for quantifying cytotoxicity, including luminescent and fluorescent assays that can be multiplexed with apoptosis or viability assays to help determine mechanism of cell death.

Glutathione Measurement Assays Promega offers assays for detecting glutathione and for measuring the ratio of reduced to oxidized glutathione as an indicator of cell health or cell signaling events.

Mitochondrial Function Assays A multiplexed, cell-based assay to monitor mitochondrial health. Measures ATP and a membrane integrity biomarker to distinguish mito-toxic mechanisms from other cytotoxic events.

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.